GSK, J&J (JNJ) and Amgen (AMGN) yesterday released positive results from small trials of...
GSK, J&J (JNJ) and Amgen (AMGN) yesterday released positive results from small trials of cancer drugs ahead of a big industry meeting in early June. GSK combined two melanoma medicines, JNJ's already approve Zytiga helped eliminate prostate cancer that hadn't yet spread, and Amgen has revived the once discarded rilotumumab for treating gastric cancer.
From other sites
Video at CNBC.com (Fri, 4:24PM)
Video at CNBC.com (Fri, 1:14PM)
Video at CNBC.com (Fri, 11:40AM)
at CNBC.com (May 28, 2015)
Video at CNBC.com (May 11, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs